Ronald H. Muhlenkamp - Muhlenkamp Q3-2011 Fund Portfolio

Ronald H. Muhlenkamp - Muhlenkamp Q3-2011 Fund Investing Strategies By Dividend Yield – Stock Capital, Investment. Here is a current portfolio update of Ronald H. Muhlenkamp’s - Muhlenkamp - portfolio movements as of Q3/2011 (September 30, 2011). In total, he has 37 stocks with a total portfolio worth of USD 362,029,000.

Ronald H. Muhlenkamp’s fund positions as of Q3/2011 with actual share movements:

Sym - Stock	Portfolio Weight	Recent activity	Reported Price*
PM - Philip Morris Intl.	6.73	Reduce 20.38%	$62.38
INTC - Intel Corp.	5.69	0	$21.33
ABT - Abbott Labs	5.65	0	$51.14
MSFT - Microsoft Corp.	5.43	0	$24.89
ADS - Alliance Data Systems	5.38	Add 40.00%	$92.70
BRK.B - Berkshire Hathaway CL B	5.33	0	$71.04
UNH - United Health Group Inc.	5.1	Reduce 40.74%	$46.12
PNC - PNC Financial Services	4.53	0	$48.19
ORCL - Oracle Corp.	4.37	Reduce 26.67%	$28.74
EXC - Exelon Corp.	4.3	Buy	$42.61
COV - Covidien Plc.	4.2	0	$44.10
CSCO - Cisco Systems	3.89	0	$15.49
LH - Laboratory Corp. of America Holding	3.71	Reduce 37.04%	$79.05
CHK - Chesapeake Energy	3.53	0	$25.55
STT - State Street Corp.	3.47	0	$32.16
SAH - Sonic Automotive Inc.	3.06	Reduce 15.64%	$10.79
PFE - Pfizer Inc.	2.69	Reduce 26.67%	$17.68
C - Citigroup Inc.	2.48	Buy	$25.62
CNX - CONSOL Energy Inc.	2.48	0	$33.93
WPRT - Westport Innovations Inc.	2.4	0	$28.93
DAL - Delta Air Lines Inc.	2.07	0	$7.50
HLX - Helix Energy Solutions	1.81	Reduce 16.67%	$13.10
ALGT - Allegiant Travel Company	1.8	Reduce 30.23%	$47.13
T - AT&T Inc.	1.65	0	$28.52
HSP - Hospira Inc.	1.48	Reduce 40.82%	$37.00
GLW - Corning Inc.	1.24	Reduce 52.48%	$12.36
FSYS - Fuel Systems Solutions Inc.	1.22	0	$19.21
RUSHA - Rush Enterprises Inc.	1.21	Add 3.33%	$14.16
LSCC - Lattice Semconductor	0.97	0	$5.25
ISSC - Innovative Solutions & Support Inc.	0.72	0	$4.83
PWER - Power-One Inc.	0.5	0	$4.50
DRWI - DragonWave Inc.	0.34	Reduce 11.32%	$3.30
STLY - Stanley Furniture Co.	0.22	0	$2.95
PHM - PulteGroup Inc.	0.22	Reduce 33.33%	$3.95
RUSHB - Rush Enterprises Inc. - CL B	0.1	0	$11.69
NVGN - Novogen Ltd.	0.04	0	$0.60
MSHL - Marshall Edwards Inc.	0	0	$1.46

Related Stock Ticker:

PM, INTC, ABT, MSFT, ADS, BRK.B, UNH, PNC, ORCL, EXC, COV, CSCO, LH, CHK, STT, SAH, PFE, C, CNX, WPRT, DAL, HLX, ALGT, T, HSP, GLW, FSYS, RUSHA, LSCC, ISSC, PWER, DRWI, STLY, PHM, RUSHB, NVGN, MSHL

10 High Margin Healthcare Dividend Shares

Perfect Healthcare Dividend Stocks With High Margins by Dividend Yield - Stock, Capital, Investment. I screened stocks from the healthcare sector with a positive dividend yield as well as an operating margin of more than 25 percent. Most of the stocks come from the medical instruments and supplies industry but the highest margin stocks are from the drug, biotechnology and diagnostic industry. 5 stocks from the screening results have a yield of more than 3 percent.

Here are the 3 top dividend stocks sorted by yield:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

PDL BioPharma (NASDAQ: PDLI) has a market capitalization of $866.97 million. The company employs 8 people, generates revenues of $344.98 million and has a net income of $91.87 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $193.52 million. Because of these figures, the EBITDA margin is 56.10 percent (operating margin 56.07 percent and the net profit margin finally 26.63 percent).


The total debt representing 178.77 percent of the company’s assets. Twelve trailing months earnings per share reached a value of $0.74. Last fiscal year, the company paid $1.00 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 8.43, Price/Sales 2.51 and Price/Book ratio is not calculable. Dividend Yield: 9.68 percent. The beta ratio is 0.54.

Long-Term Stock History Chart Of PDL BioPharma Inc. (Click to enlarge)

Long-Term History of Dividends from PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

Long-Term Dividend Yield History of PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

AstraZeneca (NYSE: AZN) has a market capitalization of $61.13 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55 percent and the net profit margin finally 24.29 percent).


The total debt representing 16.43 percent of the company’s assets and the total debt in relation to the equity amounts to 39.73 percent. Due to the financial situation, a return on equity of 36.71 percent was realized. Twelve trailing months earnings per share reached a value of $7.29. Last fiscal year, the company paid $2.55 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 6.35, Price/Sales 1.78 and Price/Book ratio 2.81. Dividend Yield: 5.83 percent. The beta ratio is 0.62.

Long-Term Stock History Chart Of AstraZeneca plc (ADR) (Click to enlarge)

Long-Term History of Dividends from AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Long-Term Dividend Yield History of AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Meridian Bioscience (NASDAQ: VIVO) has a market capitalization of $777.02 million. The company employs 525 people, generates revenues of $159.72 million and has a net income of $26.83 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $45.73 million. Because of these figures, the EBITDA margin is 28.63 percent (operating margin 25.06 percent and the net profit margin finally 16.80 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 19.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.65. Last fiscal year, the company paid $0.76 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 29.03, Price/Sales 4.86 and Price/Book ratio 5.61. Dividend Yield: 4.03 percent. The beta ratio is 0.80.

Long-Term Stock History Chart Of Meridian Bioscience, Inc. (Click to enlarge)

Long-Term History of Dividends from Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Long-Term Dividend Yield History of Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

10 High Margin Healthcare Dividend Shares (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.62 while the forward price to earnings ratio is 14.23. The dividend yield has a value of 3.46 percent. Price to book ratio is 4.28 and price to sales ratio 4.17. The operating margin amounts to 37.47 percent.

Related stock ticker symbols:

PDLI, AZN, VIVO, BMY, UTMD, AMGN, TECH, NVO, MLAB, ATRI

Selected Articles:

· Best Healthcare Stock Picks For 2012

· 12 Healthcare Dividend Stocks With Best Future EPS Growth

· 14 Healthcare Dividend Stocks With Biggest Institutional Buys

· 8 Healthcare Dividend Stocks Close to 52-Week Low

* I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.

Best Dividend Paying Stock List As Of January 2012

Best Dividend Paying Stocks Lists By Dividend Yield – Stock, Capital, Investment. Here is a current dividend list (from low-yield to high-yield paying stocks) of stocks with interesting performance and valuation figures. Stocks from that list are mid- and large caps (market capitalization of more than USD 1 billion) with double digit long-term earnings growth rates. The companies are traded at AMEX, NYSE, NASDAQ and part of the Dow Jones, S&P 500 as well as Nasdaq Composite. Date of the screen is 2012-01-01. The list is selected by the following criteria’s and sorted by dividend yield:

Market capitalization: > 1 Billion
Price/Earnings Ratio: > 0 < 100

Dividend Yield: > 3 < 20

Return on investment: > 10 < 100

Operating Margin: > 10 < 100

10 Year Revenue Growth: > 8 < 200

10 Year EPS Growth: > 10 < 100

Here are the best yielding stocks from the list:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

YPF SA (NYSE:YPF) has a market capitalization of $13.64 billion. The company employs 13,370 people, generates revenues of $10,265.46 million and has a net income of $1,345.89 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $3,428.17 million. Because of these figures, the EBITDA margin is 33.40 percent (operating margin 21.46 percent and the net profit margin finally 13.11 percent).


The total debt representing 16.72 percent of the company’s assets and the total debt in relation to the equity amounts to 40.91 percent. Due to the financial situation, the return on equity amounts to 25.51 percent. Twelve trailing months earnings per share amounts to $3.38. Last fiscal year, the company paid $2.63 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 10.26, Price/Sales 1.49 and Price/Book ratio 3.08. Dividend Yield: 9.79 percent. The beta ratio is 0.79.

Long-Term Stock Chart Of YPF SA (ADR) (Click to enlarge)

Vale (NYSE:VALE) has a market capitalization of $105.39 billion. The company employs 70,785 people, generates revenues of $45,293.00 million and has a net income of $16,609.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $24,955.00 million. Because of these figures, the EBITDA margin is 55.10 percent (operating margin 47.90 percent and the net profit margin finally 36.67 percent).


The total debt representing 20.01 percent of the company’s assets and the total debt in relation to the equity amounts to 37.51 percent. Due to the financial situation, the return on equity amounts to 27.46 percent. Twelve trailing months earnings per share amounts to $4.55. Last fiscal year, the company paid $0.57 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 4.72, Price/Sales 2.45 and Price/Book ratio 1.63. Dividend Yield: 8.19 percent. The beta ratio is 1.56.

Long-Term Stock Chart Of Vale (ADR) (Click to enlarge)

Southern Copper (NYSE:SCCO) has a market capitalization of $25.38 billion. The company employs 11,126 people, generates revenues of $5,149.50 million and has a net income of $1,562.71 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $2,885.90 million. Because of these figures, the EBITDA margin is 56.04 percent (operating margin 50.57 percent and the net profit margin finally 30.35 percent).


The total debt representing 33.96 percent of the company’s assets and the total debt in relation to the equity amounts to 70.95 percent. Due to the financial situation, the return on equity amounts to 40.02 percent. Twelve trailing months earnings per share amounts to $2.70. Last fiscal year, the company paid $1.68 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 11.17, Price/Sales 4.93 and Price/Book ratio 6.59. Dividend Yield: 8.15 percent. The beta ratio is 1.61.

Long-Term Stock Chart Of Southern Copper Corp. (Click to enlarge)

Mobile TeleSystems (NYSE:MBT) has a market capitalization of $14.60 billion. The company employs 39,911 people, generates revenues of $11,293.24 million and has a net income of $1,548.44 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $4,735.06 million. Because of these figures, the EBITDA margin is 41.93 percent (operating margin 24.21 percent and the net profit margin finally 13.71 percent).


The total debt representing 49.46 percent of the company’s assets and the total debt in relation to the equity amounts to 229.15 percent. Due to the financial situation, the return on equity amounts to 42.68 percent. Twelve trailing months earnings per share amounts to $1.23. Last fiscal year, the company paid $0.99 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 11.92, Price/Sales 1.29 and Price/Book ratio 4.50. Dividend Yield: 7.13 percent. The beta ratio is 1.45.

Long-Term Stock Chart Of Mobile TeleSystems OJS... (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 11.80 while the dividend yield has a value of 5.14 percent. Price to book ratio is 3.42 and price to sales ratio 2.17. The operating margin amounts to 32.22 percent. Earnings per share grew by 19.71 yearly over the past decade.

Best Dividend Paying Stock List As Of January 2012 (Click to enlarge)

Related Stock Ticker Symbols:

YPF, VALE, SCCO, MBT, HEP, PBR, ARLP, TLK, EOC, YZC, CHL, ABV, NVS, STRA, GRMN, TSM, SSL, BBL, CEO, LNCR

Selected Articles:

· Best Dividend Paying Stock List As Of December 2011

· Dogs of the Dow Jones Industrial Average As Of November 2011

· Cheapest Large Caps With Highest Expected Growth As Of November 2011

· The 10 Best Dividend Paying Drug Stocks

*I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.